These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 35041939)
1. A potent HDAC inhibitor blocks Toxoplasma gondii tachyzoite growth and profoundly disrupts parasite gene expression. Mouveaux T; Rotili D; Boissavy T; Roger E; Pierrot C; Mai A; Gissot M Int J Antimicrob Agents; 2022 Mar; 59(3):106526. PubMed ID: 35041939 [TBL] [Abstract][Full Text] [Related]
2. Hydroxamate-based compounds are potent inhibitors of Boissavy T; Rotili D; Mouveaux T; Roger E; Aliouat EM; Pierrot C; Valente S; Mai A; Gissot M Antimicrob Agents Chemother; 2023 Nov; 67(11):e0066123. PubMed ID: 37850734 [TBL] [Abstract][Full Text] [Related]
3. A Histone Deacetylase (HDAC) Inhibitor with Pleiotropic In Vitro Anti- Jublot D; Cavaillès P; Kamche S; Francisco D; Fontinha D; Prudêncio M; Guichou JF; Labesse G; Sereno D; Loeuillet C Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328672 [TBL] [Abstract][Full Text] [Related]
4. HDAC inhibitors Tubastatin A and SAHA affect parasite cell division and are potential anti-Toxoplasma gondii chemotherapeutics. Araujo-Silva CA; De Souza W; Martins-Duarte ES; Vommaro RC Int J Parasitol Drugs Drug Resist; 2021 Apr; 15():25-35. PubMed ID: 33360687 [TBL] [Abstract][Full Text] [Related]
5. Impaired chromatin remodelling at STAT1-regulated promoters leads to global unresponsiveness of Toxoplasma gondii-infected macrophages to IFN-γ. Lang C; Hildebrandt A; Brand F; Opitz L; Dihazi H; Lüder CG PLoS Pathog; 2012 Jan; 8(1):e1002483. PubMed ID: 22275866 [TBL] [Abstract][Full Text] [Related]
6. Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro. Strobl JS; Cassell M; Mitchell SM; Reilly CM; Lindsay DS J Parasitol; 2007 Jun; 93(3):694-700. PubMed ID: 17626366 [TBL] [Abstract][Full Text] [Related]
7. An apicomplexan bromodomain protein, TgBDP1, associates with diverse epigenetic factors to regulate essential transcriptional processes in Fleck K; McNutt S; Chu F; Jeffers V mBio; 2023 Aug; 14(4):e0357322. PubMed ID: 37350586 [TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitor MS-275 augments expression of a subset of IFN-γ-regulated genes in Toxoplasma gondii-infected macrophages but does not improve parasite control. Sumpf K; Nast R; Downie B; Salinas G; Lüder CGK Exp Parasitol; 2017 Sep; 180():45-54. PubMed ID: 28189488 [TBL] [Abstract][Full Text] [Related]
9. Activity of the histone deacetylase inhibitor FR235222 on Toxoplasma gondii: inhibition of stage conversion of the parasite cyst form and study of new derivative compounds. Maubon D; Bougdour A; Wong YS; Brenier-Pinchart MP; Curt A; Hakimi MA; Pelloux H Antimicrob Agents Chemother; 2010 Nov; 54(11):4843-50. PubMed ID: 20713670 [TBL] [Abstract][Full Text] [Related]
11. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain. Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321 [TBL] [Abstract][Full Text] [Related]
12. Pantothenate biosynthesis in Toxoplasma gondii tachyzoites is not a drug target. Howieson VM; Zeng J; Kloehn J; Spry C; Marchetti C; Lunghi M; Varesio E; Soper A; Coyne AG; Abell C; van Dooren GG; Saliba KJ Int J Parasitol Drugs Drug Resist; 2023 Aug; 22():1-8. PubMed ID: 37004488 [TBL] [Abstract][Full Text] [Related]
13. Drug inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites. Bougdour A; Maubon D; Baldacci P; Ortet P; Bastien O; Bouillon A; Barale JC; Pelloux H; Ménard R; Hakimi MA J Exp Med; 2009 Apr; 206(4):953-66. PubMed ID: 19349466 [TBL] [Abstract][Full Text] [Related]
14. Zhang Y; Zhang Q; Li H; Cong H; Qu Y Front Cell Infect Microbiol; 2022; 12():1002817. PubMed ID: 36171756 [TBL] [Abstract][Full Text] [Related]
15. Repurposing the Medicines for Malaria Venture's COVID Box to discover potent inhibitors of Toxoplasma gondii, and in vivo efficacy evaluation of almitrine bismesylate (MMV1804175) in chronically infected mice. Dos Santos BR; Ramos ABDSB; de Menezes RPB; Scotti MT; Colombo FA; Marques MJ; Reimão JQ PLoS One; 2023; 18(7):e0288335. PubMed ID: 37418497 [TBL] [Abstract][Full Text] [Related]